Stockreport

Acute Myeloid Leukemia Market Expected to Reach $2.2 Billion Dollars By 2025

SPHERIX  (SPEX) 
US:NASDAQ Investor Relations: spherix.com/investors.php
PDF PALM BEACH, Florida, Oct. 21, 2019 /PRNewswire/ -- Acute myeloid leukemia (AML) is an orphan's disease. The FDA defines an orphan's disease as a condition that affects f [Read more]